Clinical Trials Browser

Carcinoma, Neuroendocrine × Carboplatin × Endocrine × Clear all

NCT02595424 2025-12-29

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Phase 2 Active not recruiting

Somatostatinoma, Carcinoma, Neuroendocrine

NCT05599984 2025-10-20

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

CNSEndocrineThoracic

Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT04325425 2025-09-30

FOLFIRINEC

Phase 2 Recruiting

Carcinoma, Neuroendocrine

NCT04268121 2025-07-23

NEONEC

Phase 2 Recruiting

EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

NCT00193531 2023-04-11

Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoma, Neuroendocrine